UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
|
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For The Quarterly Period Ended March 31, 2017
OR
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission File Number: 814-00702
HERCULES CAPITAL, INC.
(Exact Name of Registrant as Specified in its Charter)
|
Maryland |
|
743113410 |
|
(State or Jurisdiction of Incorporation or Organization) |
|
(IRS Employer Identification No.) |
|
400 Hamilton Ave., Suite 310 Palo Alto, California (Address of Principal Executive Offices) |
|
94301 (Zip Code) |
|
|
(650) 289-3060
(Registrant’s Telephone Number, Including Area Code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this Chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer |
|
☒ |
|
Accelerated filer |
|
☐ |
|
|
|
|
|
|||
|
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
|
Emerging growth company |
|
☐ |
|
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with a new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |
|
☐ |
||||
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
On May 1, 2017, there were 82,784,765 shares outstanding of the Registrant’s common stock, $0.001 par value.
FORM 10-Q TABLE OF CONTENTS
|
|
3 |
||||||
|
Item 1. |
|
|
|
3 |
|||
|
|
|
|
|
3 |
|||
|
|
|
Consolidated Statement of Operations for the three months ended March 31, 2017 and 2016 (unaudited) |
|
5 |
|||
|
|
|
|
|
6 |
|||
|
|
|
Consolidated Statement of Cash Flows for the three months ended March 31, 2017 and 2016 (unaudited) |
|
7 |
|||
|
|
|
Consolidated Schedule of Investments as of March 31, 2017 (unaudited) |
|
8 |
|||
|
|
|
Consolidated Schedule of Investments as of December 31, 2016 (unaudited) |
|
21 |
|||
|
|
|
|
|
35 |
|||
|
Item 2. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
66 |
|||
|
Item 3. |
|
|
|
93 |
|||
|
Item 4. |
|
|
|
94 |
|||
|
|
|
95 |
|||||
|
Item 1. |
|
|
95 |
||||
|
Item 1A. |
|
|
|
95 |
|||
|
Item 2. |
|
|
|
96 |
|||
|
Item 3. |
|
|
|
96 |
|||
|
Item 4. |
|
|
|
96 |
|||
|
Item 5. |
|
|
|
96 |
|||
|
Item 6. |
|
|
|
97 |
|||
|
|
|
99 |
|||||
2
In this Quarterly Report, the “Company,” “Hercules,” “we,” “us” and “our” refer to Hercules Capital, Inc. and its wholly owned subsidiaries and its affiliated securitization trusts on or after February 25, 2016 and “Hercules Technology Growth Capital, Inc.” and its wholly owned subsidiaries and its affiliated securitization trusts prior to February 25, 2016, unless the context otherwise requires.
HERCULES CAPITAL, INC.
CONSOLIDATED STATEMENT OF ASSETS AND LIABILITIES
(unaudited)
(dollars in thousands, except per share data)
|
|
|
March 31, 2017 |
|
|
December 31, 2016 |
|
||
|
Assets |
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
Non-control/Non-affiliate investments (cost of $1,469,449 and $1,475,918 respectively) |
|
$ |
1,376,181 |
|
|
$ |
1,414,210 |
|
|
Control investments (cost of $42,751 and $22,598, respectively) |
|
|
24,775 |
|
|
|
4,700 |
|
|
Affiliate investments (cost of $12,850 and $13,010, respectively) |
|
|
5,311 |
|
|
|
5,032 |
|
|
Total investments, at value (cost of $1,525,050 and $1,511,526 respectively) |
|
|
1,406,267 |
|
|
|
1,423,942 |
|
|
Cash and cash equivalents |
|
|
148,140 |
|
|
|
13,044 |
|
|
Restricted cash |
|
|
12,924 |
|
|
|
8,322 |
|
|
Interest receivable |
|
|
11,484 |
|
|
|
11,614 |
|
|
Other assets |
|
|
7,433 |
|
|
|
7,282 |
|
|
Total assets |
|
$ |
1,586,248 |
|
|
$ |
1,464,204 |
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
|
$ |
16,513 |
|
|
$ |
21,463 |
|
|
Credit Facilities |
|
|
— |
|
|
|
5,016 |
|
|
2021 Asset-Backed Notes, net (principal of $101,411 and $109,205, respectively) (1) |
|
|
100,388 |
|
|
|
107,972 |
|
|
Convertible Notes, net (principal of $230,000 and $0, respectively) (1) |
|
|
222,542 |
|
|
|
— |
|
|
2019 Notes, net (principal of $0 and $110,364, respectively) (1) |
|
|
— |
|
|
|
108,818 |
|
|
2024 Notes, net (principal of $258,510 and $252,873, respectively) (1) |
|
|
251,240 |
|
|
|
245,490 |
|
|
SBA Debentures, net (principal of $190,200 and $190,200, respectively) (1) |
|
|
187,669 |
|
|
|
187,501 |
|
|
Total liabilities |
|
$ |
778,352 |
|
|
$ |
676,260 |
|
|
|
|
|
|
|
|
|
|
|
|
Net assets consist of: |
|
|
|
|
|
|
|
|
|
Common stock, par value |
|
|
83 |
|
|
|
80 |
|
|
Capital in excess of par value |
|
|
890,861 |
|
|
|
839,657 |
|
|
Unrealized depreciation on investments (2) |
|
|
(120,528 |
) |
|
|
(89,025 |
) |
|
Accumulated undistributed realized gains on investments |
|
|
40,840 |
|
|
|
37,603 |
|
|
Distributions in excess of net investment income |
|
|
(3,360 |
) |
|
|
(371 |
) |
|
Total net assets |
|
$ |
807,896 |
|
|
$ |
787,944 |
|
|
Total liabilities and net assets |
|
$ |
1,586,248 |
|
|
$ |
1,464,204 |
|
|
|
|
|
|
|
|
|
|
|
|
Shares of common stock outstanding ($0.001 par value, 200,000,000 authorized) |
|
|
82,801 |
|
|
|
79,555 |
|
|
Net asset value per share |
|
$ |
9.76 |
|
|
$ |
9.90 |
|
|
(1) |
The Company’s SBA Debentures, 2019 Notes, 2024 Notes, 2021 Asset-Backed Notes, and Convertible Notes, as each term is defined herein, are presented net of the associated debt issuance costs for each instrument. See “Note 4 – Borrowings”. |
|
(2) |
Amounts include $1.7 million and $1.4 million in net unrealized depreciation on other assets and accrued liabilities, including escrow receivables, estimated taxes payable and warrant participation agreement liabilities as of March 31, 2017 and December 31, 2016, respectively. |
See notes to consolidated financial statements.
3
The following table presents the assets and liabilities of our consolidated securitization trust for the 2021 Asset-Backed Notes (see Note 4), which is a variable interest entity (“VIE”). The assets of our securitization VIE can only be used to settle obligations of our consolidated securitization VIE, these liabilities are only the obligations of our consolidated securitization VIE, and the creditors (or beneficial interest holders) do not have recourse to our general credit. These assets and liabilities are included in the Consolidated Statement of Assets and Liabilities above.
|
(Dollars in thousands) |
|
March 31, 2017 |
|
|
December 31, 2016 |
|
||
|
Assets |
|
|
|
|
|
|
|
|
|
Restricted Cash |
|
$ |
12,924 |
|
|
$ |
8,322 |
|
|
Total investments, at value (cost of $214,519 and $244,695, respectively) |
|
|
213,437 |
|
|
|
242,349 |
|
|
Total assets |
|
$ |
226,361 |
|
|
$ |
250,671 |
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
2021 Asset-Backed Notes, net (principal of $101,411 and $109,205, respectively) (1) |
|
$ |
100,388 |
|
|
$ |
107,972 |
|
|
Total liabilities |
|
$ |
100,388 |
|
|
$ |
107,972 |
|
|
(1) |
The Company’s 2021 Asset-Backed Notes are presented net of the associated debt issuance costs. See “Note 4 – Borrowings”. |
See notes to consolidated financial statements.
4
CONSOLIDATED STATEMENT OF OPERATIONS
(unaudited)
(in thousands, except per share data)
|
|
Three Months Ended March 31, |
|
|||||
|
|
2017 |
|
|
2016 |
|
||
|
Investment income: |
|
|
|
|
|
|
|
|
Interest income |
|
|
|
|
|
|
|
|
Non-control/Non-affiliate investments |
$ |
42,345 |
|
|
$ |
36,409 |
|
|
Control investments |
|
514 |
|
|
|
— |
|
|
Affiliate investments |
|
2 |
|
|
|
65 |
|
|
Total interest income |
|
42,861 |
|
|
|
36,474 |
|
|
Fees |
|
|
|
|
|
|
|
|
Non-control/Non-affiliate investments |
|
3,499 |
|
|
|
2,465 |
|
|
Control investments |
|
5 |
|
|
|
— |
|
|
Total fees |
|
3,504 |
|
|
|
2,465 |
|
|
Total investment income |
|
46,365 |
|
|
|
38,939 |
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
Interest |
|
9,607 |
|
|
|
7,018 |
|
|
Loan fees |
|
2,838 |
|
|
|
988 |
|
|
General and administrative |
|
4,064 |
|
|
|
3,580 |
|
|
Employee compensation: |
|
|
|
|
|
|
|
|
Compensation and benefits |
|
5,345 |
|
|
|
4,685 |
|
|
Stock-based compensation |
|
1,833 |
|
|
|
2,571 |
|
|
Total employee compensation |
|
7,178 |
|
|
|
7,256 |
|
|
Total operating expenses |
|
23,687 |
|
|
|
18,842 |
|
|
Net investment income |
|
22,678 |
|
|
|
20,097 |
|
|
Net realized gain (loss) on investments |
|
|
|
|
|
|
|
|
Non-control/Non-affiliate investments |
|
3,288 |
|
|
|
(4,468 |
) |
|
Control investments |
|
(51 |
) |
|
|
— |
|
|
Total net realized gain (loss) on investments |
|
3,237 |
|
|
|
(4,468 |
) |
|
Net change in unrealized appreciation (depreciation) on investments |
|
|
|
|
|
|
|
|
Non-control/Non-affiliate investments |
|
(32,155 |
) |
|
|
(1,460 |
) |
|
Control investments |
|
213 |
|
|
|
— |
|
|
Affiliate investments |
|
439 |
|
|
|
126 |
|
|
Total net unrealized depreciation on investments |
|
(31,503 |
) |
|
|
(1,334 |
) |
|
Total net realized and unrealized loss |
|
(28,266 |
) |
|
|
(5,802 |
) |
|
Net increase (decrease) in net assets resulting from operations |
$ |
(5,588 |
) |
|
$ |
14,295 |
|
|
|
|
|
|
|
|
|
|
|
Net investment income before investment gains and losses per common share: |
|
|
|
|
|
|
|
|
Basic |
$ |
0.28 |
|
|
$ |
0.28 |
|
|
Change in net assets resulting from operations per common share: |
|
|
|
|
|
|
|
|
Basic |
$ |
(0.07 |
) |
|
$ |
0.20 |
|
|
Diluted |
$ |
(0.07 |
) |
|
$ |
0.20 |
|
|
Weighted average shares outstanding |
|
|
|
|
|
|
|
|
Basic |
|
81,420 |
|
|
|
71,172 |
|
|
Diluted |
|
81,420 |
|
|
|
71,199 |
|
|
Distributions declared per common share: |
|
|
|
|
|
|
|
|
Basic |
$ |
0.31 |
|
|
$ |
0.31 |
|
See notes to consolidated financial statements.
5
CONSOLIDATED STATEMENT OF CHANGES IN NET ASSETS
(unaudited)
(dollars and shares in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Undistributed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Investment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
Income/ |
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
Undistributed |
|
|
(Distributions |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
Capital in |
|
|
Appreciation |
|
|
Realized |
|
|
in Excess of |
|
|
|
|
|
||||
|
|
Common Stock |
|
|
excess |
|
|
(Depreciation) |
|
|
Gains (Losses) |
|
|
Investment |
|
|
Net |
|
||||||||||
|
|
Shares |
|
|
Par Value |
|
|
of par value |
|
|
on Investments |
|
|
on Investments |
|
|
Income) |
|
|
Assets |
|
|||||||
|
Balance at December 31, 2015 |
|
72,118 |
|
|
$ |
73 |
|
|
$ |
751,902 |
|
|
$ |
(52,808 |
) |
|
$ |
27,993 |
|
|
$ |
(10,026 |
) |
|
$ |
717,134 |
|
|
Net increase (decrease) in net assets resulting from operations |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,334 |
) |
|
|
(4,468 |
) |
|
|
20,097 |
|
|
|
14,295 |
|
|
Public offering, net of offering expenses |
|
1,109 |
|
|
|
1 |
|
|
|
12,403 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
12,404 |
|
|
Acquisition of common stock under repurchase plan |
|
(449 |
) |
|
|
— |
|
|
|
(4,789 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(4,789 |
) |
|
Issuance of common stock under restricted stock plan |
|
538 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Retired shares for restricted stock vesting |
|
(129 |
) |
|
|
— |
|
|
|
(1,385 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,385 |
) |
|
Distributions reinvested in common stock |
|
43 |
|
|
|
— |
|
|
|
496 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
496 |
|
|
Distributions |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(22,371 |
) |
|
|
(22,371 |
) |
|
Stock-based compensation (1) |
|
— |
|
|
|
— |
|
|
|
2,596 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,596 |
|
|
Balance at March 31, 2016 |
|
73,230 |
|
|
$ |
74 |
|
|
$ |
761,223 |
|
|
$ |
(54,142 |
) |
|
$ |
23,525 |
|
|
$ |
(12,300 |
) |
|
$ |
718,380 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2016 |
|
79,555 |
|
|
$ |
80 |
|
|
$ |
839,657 |
|
|
$ |
(89,025 |
) |
|
$ |
37,603 |
|
|
$ |
(371 |
) |
|
$ |
787,944 |
|
|
Net increase (decrease) in net assets resulting from operations |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(31,503 |
) |
|
|
3,237 |
|
|
|
22,678 |
|
|
|
(5,588 |
) |
|
Public offering, net of offering expenses |
|
3,309 |
|
|
|
3 |
|
|
|
46,945 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
46,948 |
|
|
Issuance of common stock due to stock option exercises |
|
24 |
|
|
|
— |
|
|
|
181 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
181 |
|
|
Retired shares from net issuance |
|
(16 |
) |
|
|
— |
|
|
|
(140 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(140 |
) |
|
Issuance of common stock under restricted stock plan |
|
4 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Retired shares for restricted stock vesting |
|
(101 |
) |
|
|
— |
|
|
|
(1,433 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,433 |
) |
|
Distributions reinvested in common stock |
|
26 |
|
|
|
— |
|
|
|
388 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
388 |
|
|
Issuance of Convertible Notes |
|
— |
|
|
|
— |
|
|
|
3,413 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,413 |
|
|
Distributions |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(25,667 |
) |
|
|
(25,667 |
) |
|
Stock-based compensation (1) |
|
— |
|
|
|
— |
|
|
|
1,850 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,850 |
|
|
Balance at March 31, 2017 |
|
82,801 |
|
|
$ |
83 |
|
|
$ |
890,861 |
|
|
$ |
(120,528 |
) |
|
$ |
40,840 |
|
|
$ |
(3,360 |
) |
|
$ |
807,896 |
|
|
(1) |
Stock-based compensation includes $17 and $25 of restricted stock and option expense related to director compensation for the three months ended March 31, 2017 and 2016, respectively. |
See notes to consolidated financial statements.
6
CONSOLIDATED STATEMENT OF CASH FLOWS
(unaudited)
(dollars in thousands)
|
|
For the Three Months Ended March 31, |
|
|||||
|
|
2017 |
|
|
2016 |
|
||
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net increase (decrease) in net assets resulting from operations |
$ |
(5,588 |
) |
|
$ |
14,295 |
|
|
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities: |
|
|
|
|
|
|
|
|
Purchase of investments |
|
(153,665 |
) |
|
|
(170,921 |
) |
|
Principal and fee payments received on investments |
|
141,798 |
|
|
|
77,808 |
|
|
Proceeds from the sale of investments |
|
11,995 |
|
|
|
4,636 |
|
|
Net unrealized depreciation on investments |
|
31,503 |
|
|
|
1,334 |
|
|
Net realized loss (gain) on investments |
|
(3,237 |
) |
|
|
4,468 |
|
|
Accretion of paid-in-kind principal |
|
(2,199 |
) |
|
|
(1,535 |
) |
|
Accretion of loan discounts |
|
(1,924 |
) |
|
|
(1,863 |
) |
|
Accretion of loan discount on Convertible Notes |
|
112 |
|
|
|
61 |
|
|
Accretion of loan exit fees |
|
(6,574 |
) |
|
|
(5,231 |
) |
|
Change in deferred loan origination revenue |
|
284 |
|
|
|
655 |
|
|
Unearned fees related to unfunded commitments |
|
976 |
|
|
|
(87 |
) |
|
Amortization of debt fees and issuance costs |
|
2,508 |
|
|
|
785 |
|
|
Depreciation |
|
52 |
|
|
|
56 |
|
|
Stock-based compensation and amortization of restricted stock grants (1) |
|
1,850 |
|
|
|
2,596 |
|
|
Change in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Interest and fees receivable |
|
130 |
|
|
|
(1,753 |
) |
|
Prepaid expenses and other assets |
|
(1,061 |
) |
|
|
(2,540 |
) |
|
Accounts payable |
|
1 |
|
|
|
(88 |
) |
|
Accrued liabilities |
|
(5,255 |
) |
|
|
(5,029 |
) |
|
Net cash provided by (used in) operating activities |
|
11,706 |
|
|
|
(82,353 |
) |
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchases of capital equipment |
|
(39 |
) |
|
|
(127 |
) |
|
Reduction of (increase in) restricted cash |
|
(4,602 |
) |
|
|
5,545 |
|
|
Net cash (used in) provided by investing activities |
|
(4,641 |
) |
|
|
5,418 |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Issuance of common stock, net |
|
46,948 |
|
|
|
12,404 |
|
|
Repurchase of common stock, net |
|
— |
|
|
|
(4,789 |
) |
|
Retirement of employee shares |
|
(1,392 |
) |
|
|
(1,385 |
) |
|
Distributions paid |
|
(25,279 |
) |
|
|
(21,875 |
) |
|
Issuance of Convertible Notes |
|
230,000 |
|
|
|
— |
|
|
Issuance of 2024 Notes Payable |
|
5,637 |
|
|
|
— |
|
|
Repayments of 2019 Notes Payable |
|
(110,365 |
) |
|
|
— |
|
|
Repayments of 2021 Asset-Backed Notes |
|
(7,794 |
) |
|
|
— |
|
|
Borrowings of credit facilities |
|
8,497 |
|
|
|
106,666 |
|
|
Repayments of credit facilities |
|
(13,513 |
) |
|
|
(95,663 |
) |
|
Cash paid for debt issuance costs |
|
(4,456 |
) |
|
|
— |
|
|
Fees paid for credit facilities and debentures |
|
(252 |
) |
|
|
(141 |
) |
|
Net cash provided by (used in) financing activities |
|
128,031 |
|
|
|
(4,783 |
) |
|
Net increase (decrease) in cash and cash equivalents |
|
135,096 |
|
|
|
(81,718 |
) |
|
Cash and cash equivalents at beginning of period |
|
13,044 |
|
|
|
95,196 |
|
|
Cash and cash equivalents at end of period |
$ |
148,140 |
|
|
$ |
13,478 |
|
|
|
|
|
|
|
|
|
|
|
Supplemental non-cash investing and financing activities: |
|
|
|
|
|
|
|
|
Distributions reinvested |
|
388 |
|
|
|
496 |
|
|
(1) |
Stock-based compensation includes $17 and $25 of restricted stock and option expense related to director compensation for the three months ended March 31, 2017 and 2016, respectively. |
See notes to consolidated financial statements.
7
CONSOLIDATED SCHEDULE OF INVESTMENTS
March 31, 2017
(unaudited)
(dollars in thousands)
|
Portfolio Company |
|
Sub-Industry |
|
Type of Investment(1) |
|
Maturity Date |
|
Interest Rate and Floor |
|
Principal Amount |
|
|
Cost(2) |
|
|
Value(3) |
|
|||
|
Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Biotechnology Tools |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Exicure, Inc. (11)(14A) |
|
Biotechnology Tools |
|
Senior Secured |
|
September 2019 |
|
Interest rate PRIME + 6.45% or Floor rate of 9.95% |
|
$ |
6,000 |
|
|
$ |
6,008 |
|
|
$ |
6,089 |
|
|
Subtotal: 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
6,008 |
|
|
|
6,089 |
|
||
|
Subtotal: Biotechnology Tools (0.75%)* |
|
|
|
|
|
|
|
|
|
|
|
|
6,008 |
|
|
|
6,089 |
|
||
|
Communications & Networking |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Achilles Technology Management Co II, Inc. (6)(13)(14B) |
|
Communications & Networking |
|
Senior Secured |
|
August 2017 |
|
PIK Interest 10.50% |
|
$ |
1,312 |
|
|
|
1,378 |
|
|
|
1,378 |
|
|
OpenPeak, Inc. (7) |
|
Communications & Networking |
|
Senior Secured |
|
April 2017 |
|
Interest rate PRIME + 8.75% or Floor rate of 12.00% |
|
$ |
12,211 |
|
|
|
8,975 |
|
|
|
— |
|
|
SkyCross, Inc. (6)(7)(14B)(15) |
|
Communications & Networking |
|
Senior Secured |
|
January 2018 |
|
Interest rate FIXED 10.95%, PIK Interest 5.00% |
|
$ |
16,758 |
|
|
|
16,900 |
|
|
|
2,103 |
|
|
Subtotal: Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
27,253 |
|
|
|
3,481 |
|
||
|
1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Spring Mobile Solutions, Inc. (12)(14B) |
|
Communications & Networking |
|
Senior Secured |
|
January 2019 |
|
Interest rate PRIME + 6.70% or Floor rate of 9.95% |
|
$ |
3,000 |
|
|
|
3,063 |
|
|
|
3,069 |
|
|
Subtotal: 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
3,063 |
|
|
|
3,069 |
|
||
|
Subtotal: Communications & Networking (0.81%)* |
|
|
|
|
|
|
|
|
|
|
|
|
30,316 |
|
|
|
6,550 |
|
||
|
Consumer & Business Products |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antenna79 (p.k.a. Pong Research Corporation) (14A)(15) |
|
Consumer & Business Products |
|
Senior Secured |
|
December 2019 |
|
Interest rate PRIME + 7.45% or Floor rate of 10.95% |
|
$ |
20,000 |
|
|
|
19,911 |
|
|
|
20,130 |
|
|
|
|
Consumer & Business Products |
|
Senior Secured |
|
December 2018 |
|
Interest rate PRIME + 6.00% or Floor rate of 9.50% |
|
$ |
1,000 |
|
|
|
1,000 |
|
|
|
1,000 |
|
|
Total Antenna79 (p.k.a. Pong Research Corporation) |
|
|
|
|
|
|
|
$ |
21,000 |
|
|
|
20,911 |
|
|
|
21,130 |
|
||
|
Second Time Around (Simplify Holdings, LLC) (7)(14A)(15) |
|
Consumer & Business Products |
|
Senior Secured |
|
February 2019 |
|
Interest rate PRIME + 7.25% or Floor rate of 10.75% |
|
$ |
2,069 |
|
|
|
2,104 |
|
|
|
— |
|
|
Subtotal: 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
23,015 |
|
|
|
21,130 |
|
||
|
Subtotal: Consumer & Business Products (2.62%)* |
|
|
|
|
|
|
|
|
|
|
|
|
23,015 |
|
|
|
21,130 |
|
||
|
Drug Delivery |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Celsion Corporation (10)(14A) |
|
Drug Delivery |
|
Senior Secured |
|
June 2017 |
|
Interest rate PRIME + 8.00% or Floor | ||||||||||||